Chengdu Olymvax Biopharmaceuticals Inc. (SHA:688319)
25.08
-0.61 (-2.37%)
Nov 17, 2026, 3:00 PM CST
| Market Cap | 10.17B +1.0% |
| Revenue (ttm) | 796.18M +12.3% |
| Net Income | -32.02M |
| EPS | -0.08 |
| Shares Out | 405.41M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 3,295,894 |
| Open | 25.51 |
| Previous Close | 25.69 |
| Day's Range | 24.78 - 25.92 |
| 52-Week Range | 20.41 - 44.90 |
| Beta | 0.67 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 30, 2026 |